Related Experiment Video
Updated: Sep 25, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Advancing Care and Outcomes for African American Patients With Multiple Sclerosis
Annette F Okai1, Annette M Howard2, Mitzi J Williams2
1From the North Texas Institute of Neurology and Headache (A.F.O.), Plano; Multiple Sclerosis Institute of Texas (A.M.H.), Houston; Joi Life Wellness Multiple Sclerosis Neurology Center (M.J.W.), Smyrna, GA; Providence Brain and Spine Institute (J.D.B., C.C., T.L.S., E.B., S.L.C.), Portland, OR; and Alphabet Health (G.J.), New York. aokaimd@outlook.com.
Abstract:
Multiple sclerosis (MS) has historically been underdiagnosed and undertreated among African Americans. Recent evidence suggests that African Americans with MS have a different clinical presentation, increased disease incidence and burden, and worse long-term outcomes vs their White counterparts. Due to limited data available for African Americans in MS clinical trials, it is difficult to make informed, generalizable conclusions about the natural history, prognosis, and therapeutic response in this population. In this narrative review, we highlight the nature and magnitude of the health disparities experienced by African Americans with MS and underscore the pressing need to increase knowledge about and understanding of MS disease manifestations in this group. In addition, we describe the mission and objectives of the recently established National African Americans with Multiple Sclerosis Registry, which is intended to be a platform to advance the care of African Americans with MS and address health disparities they may experience.
Insights
African Americans with multiple sclerosis (MS) face health disparities, including underdiagnosis and worse outcomes. New research and registries aim to improve understanding and care for this population.
Area of Science:
- Neurology
- Health Disparities Research
- Clinical Epidemiology
Background:
- Multiple sclerosis (MS) is often underdiagnosed and undertreated in African Americans.
- Evidence indicates African Americans with MS experience distinct clinical presentations, higher disease burden, and poorer long-term outcomes compared to White individuals.
- Limited clinical trial data for African Americans hinders understanding of MS natural history, prognosis, and treatment response in this demographic.
Purpose of the Study:
- To review the health disparities in multiple sclerosis (MS) experienced by African Americans.
- To emphasize the need for increased knowledge regarding MS manifestations in African Americans.
- To introduce the National African Americans with Multiple Sclerosis Registry as a platform to advance care and address disparities.
Main Methods:
- This study is a narrative review.
- It synthesizes existing evidence on MS in African Americans.
- It describes the goals of a new registry.
Main Results:
- African Americans with MS face significant health disparities.
- There is a critical lack of generalizable data on MS in this population.
- A new registry has been established to address these gaps.
Conclusions:
- Addressing health disparities in African Americans with MS is crucial.
- Further research and data collection, such as through the new registry, are essential to improve understanding and outcomes.
- Enhanced knowledge of MS in African Americans will facilitate more equitable and effective care.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease IV: Nursing Management
Atherosclerosis III: Management
Patient-centered Care
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities

